- By investing in drug research and nurturing local talent, Emcure is not only contributing to Gujarat’s growth but also strengthening India’s position as a global leader in pharmaceuticals: Rushikeshbhai Patel
- Over the past four decades, Emcure has remained steadfast in its commitment to pushing the boundaries of pharmaceutical research and development, creating innovative solutions for unmet medical challenges: Satish Mehta, Founder and CEO, Emcure Pharmaceuticals
- The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations.
- Emcure’s ERC aims to drive breakthrough research and develop transformative therapies to enhance patient care
- Out of the total 550 R&D staffers, 350, including 100 freshers will work in this facility
NE HEALTH BUREAU
AHMEDABAD, JAN 24
Gujarat Health and Family Welfare Minister Rushikeshbhai Patel inaugurated Emcure Pharmaceuticals Limited, one of India’s leading pharma companies, state-of-the-art Formulation Research and Development (R&D) Centre near Tapovan Circle, Ahmedabad. The Emcure Research Centre (ERC) is strategically designed to enable breakthroughs in complex drug delivery systems, such as sustained-release formulations, liposomal injections and advanced dermal therapies.
Commenting on the occasion, Gujarat Health and Family Welfare Minister Rushikeshbhai Patel said, “It gives me great pride to inaugurate Emcure Pharmaceuticals’ advanced R&D center in Ahmedabad. Gujarat has always been a hub for innovation and progress, and this facility is a shining example of how we can create futuristic healthcare solutions. By investing in drug research and nurturing local talent, Emcure is not only contributing to Gujarat’s growth but also strengthening India’s position as a global leader in pharmaceuticals. I compliment the entire team at Emcure for this remarkable achievement”.
The new ERC facility is designed to accelerate pharmaceutical innovation with state-of-the-art laboratories and advanced equipment for each of the dosage forms. From early-stage pre-formulation studies to scaling-up, the ERC seamlessly integrates all aspects of pharmaceutical development while adhering to global regulatory standards.
Industry-academia collaboration is hallmark of Emcure
Satish Mehta, Founder and CEO, Emcure Pharmaceuticals, said, “In a shining example of industry-academia collaboration, out of total 550 R&D team in various facilities, a team of 350 highly skilled professionals, including doctorate, post-graduate and graduate, especially 100 freshers specializing in pharmaceutical sciences, bio-engineering, analytical chemistry, pharmacovigilance and regulatory affairs will work together to develop novel formulations, enhance drug bioavailability and create patient-centric delivery solutions.”
“With a focus on sustainable solutions and green chemistry practices, the Emcure Research Centre reflects the company’s dedication to environmentally conscious innovations. It also serves as a catalyst for job creation and collaborations with academic institutions, industry experts and regulatory bodies, promoting an ecosystem of shared knowledge and growth. This lab is open to the faculties as well as research scholars of Ganpat University, LM College of Pharmacy and other leading pharma institutes in the larger interest of human kind,” added Satish Mehta.
“Over the past four decades, Emcure has remained steadfast in its commitment to pushing the boundaries of pharmaceutical research and development, creating innovative solutions for unmet medical challenges. We will invest more in Gujarat to scale-up R&D and manufacturing capacities,” said Satish Mehta, Founder and CEO, Emcure Pharmaceuticals. “This new R&D centre represents a significant milestone in our continued pursuit of innovation, by combining advanced research technology with a talented team. With a focus on both efficiency and quality, the centre is set to drive advancements that will reshape the future of medicine globally”, he concluded.
By developing differentiated products for all regulated, emerging and domestic markets, ERC further solidifies Gujarat’s status as a hub for pharmaceutical research.
Gujarat Minister of State for Home Harsh Sanghvi, Gujarat FDCA Commissioner Dr Hemant Koshiya and who’s who of pharma industries and educational institutes were also present at the event.
